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Estrogens and Development
by John A. McLachlan* and Retha R. Newbold*
The normal development of the genital organs of mammals, including humans, is under hormonal
control. A role for the female sex hormone estrogen in this process is still unclear. However, exposure of
experimental animals or humans to the potent exogenous estrogen, diethylstilbestrol (DES), results in
persistent differentiation effects. Since many chemicals in the environment are weakly estrogenic, the
possibility of hormonally altered differentiation must be considered.
The development ofthe mammalian genital tract in-
volves the remodeling of two fetal duct systems: the
Miullerian or female genital precursor and the Wolffian
or male counterpart. This process is apparently con-
trolled, in the main, by two secretions from the fetal
testes. In a genetic male, fetal testicular androgen is
required for maintenance of the male genital anlage,
while a peptide factor secreted by the testis, Mullerian
inhibiting substance (MIS), determines the regression
ofthe female duct system. In the absence ofthese two
testicular factors, sex differentiation proceeds along fe-
male lines (1).
Currently it is unclear whether estrogens, either of
maternal or fetal origin, play a role in sex differentia-
tion. Although the human or rodent fetus is bathed in
endogenous estrogens, these compounds are thought to
berelatively inactiveinthefetalgenitalsystembecause
they bind to extracellular carrier proteins, are conju-
gated, and metabolized to inactive forms.
However, it is clear that exposure to exogenous es-
trogens during fetal development will profoundly alter
sexual differentiation. Experiments in mice that were
treated with the synthetic estrogen, diethylstilbestrol
(DES), demonstrated two salient features (2): the con-
tralateral fetal genital duct system was retained into
adulthood in both male and female offspring; in other
words, DES-treated females retainedboth afemale and
male genital duct system as did treated males; and the
ductal system consistent with the sex of the DES-
treated mouse had numerous structural and functional
defects along its length. For example, the Mullerian
duct, whichgivesrise (startingcranially)totheoviduct,
uterus, cervix, and upper vagina, had malformations of
each of these organs in developmentally estrogenized
females; moreover, functional defects including growth
control derangements resulting in cancers are also seen
in organs derived from the Mullerian duct.
Very similar defects are seen in women exposed in
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utero to DES. In fact, retention ofWolffian ducttissues
as ovarian cysts (3), oviductal malformation (4,5), uter-
ine abnormalities (6,7), and vaginal cancers (8,9) have
been reported in both species. Thus, structural and
functional defects are induced in the genital tracts of
both species exposed to an exogenous estrogen during
sex differentiation. The mechanism(s) underlyingthese
defects are still not known. However, persistent alter-
ations in expression of specific proteins can be demon-
strated in the genital tracts of DES-treated mice (10).
Thus, changes in the rate of cell/tissue differentiation,
as well as induction ofmolecular defects within the tar-
get cell, are apparently involved.
These findings with the potent synthetic estrogen,
DES, provide a possibly exaggerated model for what
mightbeseenwithmuchweakerestrogenicxenobiotics,
manyofwhicharecommonfeaturesinourenvironment.
As seen in Figure 1, compounds ofdiverse structure all
share a common biological end point-estrogenicity.
Coumestrol and equol are examples ofphytoestrogens,
estrogenic chemicals which are made in over 300 dif-
ferent plants. Another naturally occurring estrogen is
zearalenone, a mycotoxin produced by a fungus that
infests corn. Both the polycyclic aromatic hydrocarbon,
benz[a]anthracene, and the chlorinated hydrocarbon,
o,p'-DDT, are examples of prohormones, those com-
pounds that must first be metabolized to achieve hor-
monal activity. In each case, hydroxylation increases
the estrogenic potency ofthe compound. Furthernore,
in the cases of chlorinated chemicals like DDT and ke-
pone, their biological persistence exaggerates the hor-
monal activity in the living organism.
Themolecularbasisforestrogenicactivityisnotread-
ily apparent from the X-ray crystal structures of dif-
ferent chemicals in this class (11); nor are models ofthe
estrogen receptor-ligand interaction totally satisfying
(12). However, the structure diversity in this group of
chemicals provides numerous routes for exposure to
them.
Isthere evidenceforintoxicationwith environmental
estrogens other than DES? Among animals this cer-26 MCLACHLAN AND NEWBOLD
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FIGURE 1. Chemicals reported to be estrogenic. Selected references include: estradiol and diethylstilbestrol (22); coumestrol and equol (23);
zearalenone (24); 3,9-dihydroxybenz[a]anthracene (25); o,p-DDT (26); kepone (27); tetrahydrocannabinol (28).
tainly is the case. Sheep grazing on clover rich in phy-
toestrogens experience widespread infertility; this con-
dition is associated with the naturally occurring plant
hormones and is known as "clover disease" (13). The
fertility of quail has been shown to be strictly related
tothe concentration ofphytoestrogens intheirdiet(14).
In times ofdrought, the effective estrogenic content of
the diet is increased and reproduction markedly dimun-
ished. Likewise, a recent study with captive cheetahs
has raised the possibility that the presence ofphytoes-
trogens in their commercial diet plays a role in the in-
fertility common to this species in zoos (15).
The estrogenicmycotoxin zearalenone isproduced by
a fungus which infests corn in silage. Pigs that eat the
infested corn show signs of hyperestroginization ("the
moldy corn syndrome"). This manifestation has been
clearly associated with zearalenone, the fungal product
(16).
Evidence for human intoxication is not so obvious;
that which has been reported usually involves young-
sters and the expression oftwo common parameters of
estrogenization in prepubertal humans: breast growth
inboys and girls and menstruation in girls. These cases
appear to have another common element, i.e., inad-
vertent contamination with the potent synthetic estro-
gen, DES. Theroutes ofexposure include, forexample,
the parent's clothing, contaminated vitamin pills, or
meat (17). These examples reinforce the special sensi-
tivity of the developing mammary gland (18) and re-
productive system to the effects ofestrogens.
Most recently, reports of premature sexual devel-
opment (primarily precocious breast development, or
premature thelarche) inyounggirlsinPuerto Ricohave
raisedthe possibility ofwidespread exposure to, orcon-
tamination with, environmental estrogens (19). Since
the first report ofpremature thelarche in 1982 (20,21),
several studies have been directed toward understand-
ing the nature and etiology ofthis condition; currently
little is known and much remains to be done. However,
the possibility that exogenous estrogens may modify
sexual development or function presents a formidable
problem for scientists and clinicians. The structural ba-
sis for the biological activity of estrogen, the special
sensitivity of the immature individual to this class of
chemicals, and the outcome for developmentally estro-
genized animals and humans are each areas requiring
investigation if we are to understand completely this
new category ofenvironmental compounds, hormonally
active xenobiotics.
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